Literature DB >> 33811548

Author's reply to Letter to the Editor: "Five-year results of vocal fold augmentation using autologous fat or calcium hydroxylapatite".

Karol Zeleník1,2, Martin Formánek3,4, Radana Walderová3,4, Debora Formánková3,4, Pavel Komínek3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33811548     DOI： 10.1007/s00405-021-06784-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  5 in total

1.  Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection.

Authors:  Karol Zeleník; Radana Walderová; Hana Kučová; Debora Jančatová; Pavel Komínek
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-06       Impact factor: 2.503

2.  Five-year results of vocal fold augmentation using autologous fat or calcium hydroxylapatite.

Authors:  Karol Zeleník; Martin Formánek; Radana Walderová; Debora Formánková; Pavel Komínek
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-11-23       Impact factor: 2.503

3.  Efficacy of trans-nasal fiberendoscopic injection laryngoplasty with centrifuged autologous fat in the treatment of glottic insufficiency due to unilateral vocal fold paralysis.

Authors:  A Ricci Maccarini; M Stacchini; F Mozzanica; A Schindler; E Basile; G DE Rossi; P Woo; M Remacle; M Magnani
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

4.  Vocal fold augmentation with calcium hydroxylapatite: twelve-month report.

Authors:  Clark A Rosen; Jackie Gartner-Schmidt; Roy Casiano; Timothy D Anderson; Felicia Johnson; Marc Remacle; Robert T Sataloff; Jean Abitbol; Gary Shaw; Sanford Archer; Richard I Zraick
Journal:  Laryngoscope       Date:  2009-05       Impact factor: 3.325

5.  Transnasal endoscopic microfractured fat injection in glottic insufficiency.

Authors:  A M Saibene; C Pipolo; R Lorusso; S M Portaleone; G Felisati
Journal:  B-ENT       Date:  2015       Impact factor: 0.082
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.